Why the study?
Does VExUS-guided decongestion improve Kidney Function Recovery in patients with Cardiorenal Syndrome 1?
Population
Patients with Cardiorenal Syndrome 1 (CRS1)
Design
RCT
Authors
Loading...
Does not support VExUS guidance to improve kidney recovery; extends evidence on decongestion achievement in cardiorenal syndrome.
Does VExUS-guided decongestion improve Kidney Function Recovery in patients with Cardiorenal Syndrome 1?
In patients with cardiorenal syndrome type 1, VExUS-guided decongestion improves the odds of achieving decongestion but does not improve the probability of kidney function recovery.
Islas-Rodríguez et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: